Watchlist Price Alert

Carisma Therapeutics Inc. (CARM)

NASDAQ: CARM · Real-Time Price · USD

0.25

0.05 (23.82%)

At close: May 02, 2025, 3:59 PM

0.24

-4.20%

After-hours: May 02, 2025, 05:28 PM EDT

Carisma Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	19.63M	14.92M	9.83M	26.54M	11.24M	n/a	n/a	425K	29.98M
Cost of Revenue	n/a	74.13M	6.09M	85K	n/a	219K	208K	n/a	n/a
Gross Profit	19.63M	-59.21M	3.74M	26.46M	11.24M	-219K	-208K	425K	29.98M
Operating Income	-62.18M	-88.73M	-56.16M	-40.79M	-28.38M	-36.87M	-25.7M	-19.98M	6.17M
Interest Income	1.7M	1.94M	1.85M	10K	29K	n/a	n/a	n/a	n/a
Pretax Income	-60.48M	-86.88M	-61.23M	-40.78M	-28.35M	-107.5M	-33.69M	-29.03M	1.9M
Net Income	-60.48M	-86.88M	-61.23M	-40.77M	-28.32M	-107.5M	-33.69M	-29.03M	1.89M
Selling & General & Admin	22.14M	29.52M	3.29M	6.41M	5.09M	12.21M	11.62M	7.9M	11.44M
Research & Development	59.67M	74.13M	56.62M	34.39M	23.29M	24.44M	13.87M	12.22M	12.2M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	81.81M	103.65M	59.91M	40.79M	28.38M	36.65M	25.49M	20.13M	23.64M
Interest Expense	n/a	n/a	3.15M	n/a	n/a	n/a	n/a	n/a	247K
Selling & Marketing Expenses	n/a	n/a	30.41M	n/a	n/a	n/a	n/a	-170K	-3.3M
Cost & Expenses	81.81M	103.65M	66M	40.79M	28.38M	36.87M	25.7M	20.41M	23.82M
Income Tax Expense	n/a	n/a	-3.88M	-10K	-29K	n/a	46.86K	n/a	5K
Shares Outstanding (Basic)	41.46M	33.52M	106.4K	9.12M	5.91M	4.55M	3.09M	1.31M	1.05M
Shares Outstanding (Diluted)	41.46M	33.52M	106.4K	9.12M	5.91M	4.55M	3.09M	1.31M	1.09M
EPS (Basic)	-1.46	-2.59	-575.42	-4.47	-4.79	-23.64	-10.91	-22.24	1.79
EPS (Diluted)	-1.46	-2.59	-575.42	-4.47	-4.79	-23.64	-10.91	-22.24	1.74
EBITDA	-57.12M	-85.89M	-51.99M	-40.11M	-27.93M	-107.28M	-33.48M	-28.74M	2.32M
EBIT	-62.18M	-88.73M	-58.08M	-40.79M	-28.38M	-107.5M	-33.69M	-29.03M	2.14M
Depreciation & Amortization	3.35M	2.84M	6.09M	85K	122K	219K	208K	285K	178K